The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Open accessAbstract
Diabetic nephropathy (DN) is a major healthcare challenge. It occurs in up to 50% of those living with diabetes, is a major cause of end‐stage kidney disease (ESKD) that requires treatment with dialysis or renal transplantation, and is associated with significantly increased cardiovascular morbidity and mortality. DN is a clinical syndrome characterized by persistent albuminuria and a progressive decline in renal function, but it is increasingly recognized that the presentation and clinical course of kidney disease in diabetes is heterogeneous. The term diabetic kidney disease (DKD) is now commonly used to encompass the spectrum of people with diabetes who have either albuminuria or reductions in renal function. In this article, the clinical presentation and approach to diagnosis of DKD will be discussed, as will its prognosis. The general principles of management of DKD will also be reviewed with reference to current international guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“05).(78,104) There are few data examining similar approaches in T1DM.”
Background(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31149-3 · Cited by 3,163
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401 · cited 9×
“As well as indicating increased cardiovascular risk in both T1DM and T2DM,20,21 the traditional paradigm is that the onset of moderately increased albuminuria (A2), previously termed microalbuminuria, predicts the onset of established DN.22-25 A number of studies have reported this relationship in both T1DM and T2DM.”
BackgroundInfluentialA Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Tangri, N. (2011) · JAMA · doi:10.1001/jama.2011.451 · Cited by 1,348
Liraglutide and renal outcomes in type 2 diabetes
Mann, J. F. E., Ørsted, D. D., Brown-Frandsen, K., Marso, S. P., Poulter, N. R., Rasmussen, S., Tornøe, K., Zinman, B., & Buse, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616011 · Cited by 1,253
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., & Deckert, T. (1983) · Diabetologia · doi:10.1007/bf00284458 · Cited by 1,067
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J., & Mustonen, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042274 · Cited by 910
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis
Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Tuttle, K. R., Lakshmanan, M. C., Rayner, B., Busch, R. S., Zimmermann, A. G., Woodward, D. B., & Botros, F. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30104-9 · Cited by 648
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Parving, H.-H., Oxenbøll, B., Svendsen, P. A., Christiansen, J. S., & Andersen, A. R. (1982) · Acta Endocrinologica · doi:10.1530/acta.0.1000550 · Cited by 572
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
Leung, N., Bridoux, F., Batuman, V., Chaidos, A., Cockwell, P., D’Agati, V. D., Dispenzieri, A., Fervenza, F. C., Fermand, J.-P., Gibbs, S., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0077-4 · Cited by 551
See, E. J., Jayasinghe, K., Glassford, N., Bailey, M., Johnson, D. W., Polkinghorne, K. R., Toussaint, N. D., & Bellomo, R. (2019) · Kidney International · doi:10.1016/j.kint.2018.08.036 · Cited by 532
Parving, H.-H., Lewis, J. B., Ravid, M., Remuzzi, G., & Hunsicker, L. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000377 · Cited by 527
Parving, H.-H., Hommel, E., Mathiesen, E., Skott, P., Edsberg, B., Bahnsen, M., Lauritzen, M., Hougaard, P., & Lauritzen, E. (1988) · BMJ · doi:10.1136/bmj.296.6616.156 · Cited by 448
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
Parving, H.-H., Gall, M.-A., Skøtt, P., Jørgensen, H. E., Løkkegaard, H., Jørgensen, F., Nielsen, B., & Larsen, S. (1992) · Kidney International · doi:10.1038/ki.1992.118 · Cited by 440
Hovind, P., Tarnow, L., Rossing, P., Graae, M., Torp, I., Binder, C., & Parving, H.-H. (2004) · BMJ · doi:10.1136/bmj.38070.450891.fe · Cited by 432
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Lopez, A., & Marantz, P. R. (1994) · PubMed · Cited by 424
Bakris, G. L., Copley, J. B., Vicknair, N., Sadler, R., & Leurgans, S. (1996) · Kidney International · doi:10.1038/ki.1996.480 · Cited by 417
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 411
Patterns of renal injury in NIDDM patients with microalbuminuria
Fioretto, P., Mauer, M., Brocco, E., Velussi, M., Frigato, F., Muollo, B., Sambataro, M., Abaterusso, C., Baggio, B., Crepaldi, G., et al. (1996) · Diabetologia · doi:10.1007/s001250050616 · Cited by 410
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
Current issues in measurement and reporting of urinary albumin excretion
Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381
Viberti, G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510280037029 · Cited by 381
Progression of nephropathy in type 2 diabetic patients
Rossing, K., Christensen, P. K., Hovind, P., Tarnow, L., Rossing, P., & Parving, H.-H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00925.x · Cited by 343
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Krolewski, A. S., Niewczas, M. A., Skupien, J., Gohda, T., Smiles, A., Eckfeldt, J. H., Doria, A., & Warram, J. H. (2014) · Diabetes Care · doi:10.2337/dc13-0985 · Cited by 276
Ansquer, J.-C., Foucher, C., Rattier, S., Taskinen, M.-R., & Steiner, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.11.004 · Cited by 264
Heterogeneous nature of renal lesions in type II diabetes.
Gambara, V, Mecca, G., Remuzzi, G., & Bertani, T. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v381458 · Cited by 257
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
Mazzucco, G., Bertani, T., Fortunato, M., Bernardi, M., Leutner, M., Boldorini, R., & Monga, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31988 · Cited by 238
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group (2007) · Diabetes Care · doi:10.2337/dc06-1998 · Cited by 230
He, F., Xia, X., Wu, X. F., Yu, X. Q., & Huang, F. X. (2013) · Diabetologia · doi:10.1007/s00125-012-2796-6 · Cited by 228
Ekinci, E. I., Jerums, G., Skene, A., Crammer, P., Power, D., Cheong, K. Y., Panagiotopoulos, S., McNeil, K., Baker, S. T., Fioretto, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2572 · Cited by 223
Cellular Basis of Diabetic Nephropathy
Caramori, M. L., Kim, Y., Huang, C., Fish, A. J., Rich, S. S., Miller, M. E., Russell, G., & Mauer, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2.506 · Cited by 216
Clinical predictive factors in diabetic kidney disease progression
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12533 · Cited by 208
Ali, M. K., Bullard, K. M., Saydah, S., Imperatore, G., & Gregg, E. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30027-5 · Cited by 208
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
The Microalbuminuria Captopril Study Group (1996) · Diabetologia · doi:10.1007/bf00403306 · Cited by 208
Grams, M. E., Sang, Y., Ballew, S. H., Carrero, J. J., Djurdjev, O., Heerspink, H. J. L., Ho, K., Ito, S., Marks, A., Naimark, D., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.009 · Cited by 201
Chronic kidney disease in adults: assessment and management
Forbes, A., & Gallagher, H. (2020) · Clinical Medicine · doi:10.7861/clinmed.cg.20.2 · Cited by 201
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Yu, S. M.-W., & Bonventre, J. V. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.005 · Cited by 175
The GFR and GFR decline cannot be accurately estimated in type 2 diabetics
Gaspari, F., Ruggenenti, P. L., Porrini, E., Motterlini, N., Cannata, A. N., Carrara, F., Jiménez, A., Cella, C., Ferrari, S., Stucchi, N., et al. (2013) · Kidney International · doi:10.1038/ki.2013.47 · Cited by 153
Koye, D. N., Magliano, D. J., Reid, C. M., Jepson, C., Feldman, H. I., Herman, W. H., & Shaw, J. E. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.364 · Cited by 145
Koye, D. N., Shaw, J. E., Reid, C. M., Atkins, R. C., Reutens, A. T., & Magliano, D. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13324 · Cited by 140
Estimating renal function in old people: an in-depth review
Raman, M., Middleton, R., Kalra, P. A., & Green, D. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1682-z · Cited by 137
An autopsy study suggests that diabetic nephropathy is underdiagnosed
Klessens, C. Q. F., Woutman, T. D., Veraar, K. A. M., Zandbergen, M., Valk, E. J. J., Rotmans, J. I., Wolterbeek, R., BRUIJN, J. A., & Bajema, I. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.023 · Cited by 129
A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases
Zhou, J., Chen, X., Xie, Y., Li, J., Yamanaka, N., & Tong, X. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm897 · Cited by 127
Remission of nephrotic range proteinuria in type I diabetes
Hebert, L. A., Bain, R. P., Verme, D., Cattran, D. C., Whittier, F. C., Tolchin, N., Rohde, R. D., Lewis, E. J., Lewis, E. J., Rohde, R., et al. (1994) · Kidney International · doi:10.1038/ki.1994.469 · Cited by 124
Oellgaard, J., Gæde, P., Rossing, P. R., Persson, F., Parving, H., & Pedersen, O. B. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.023 · Cited by 124
Biological Variability of Estimated GFR and Albuminuria in CKD
Waikar, S. S., Rebholz, C. M., Zheng, Z., Hurwitz, S., Hsu, C., Feldman, H. I., Xie, D., Liu, K. D., Mifflin, T. E., Eckfeldt, J. H., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.023 · Cited by 123
Yamanouchi, M., Furuichi, K., Hoshino, J., Toyama, T., Hara, A., Shimizu, M., Kinowaki, K., Fujii, T., Ohashi, K., Yuzawa, Y., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1320 · Cited by 121
Buyadaa, O., Magliano, D. J., Salim, A., Koye, D. N., & Shaw, J. E. (2019) · Diabetes Care · doi:10.2337/dc19-1438 · Cited by 112
Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
de Boer, I. H., Afkarian, M., Rue, T. C., Cleary, P. A., Lachin, J. M., Molitch, M. E., Steffes, M. W., Sun, W., & Zinman, B. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091004 · Cited by 101
(2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.04.007 · Cited by 93
Amin, A. P., Whaley‐Connell, A. T., Li, S., Chen, S., McCullough, P. A., & Kosiborod, M. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.005 · Cited by 92
Does Microalbuminuria Predict Diabetic Nephropathy?
Parving, H.-H., Chaturvedi, N., Viberti, G. C., & Mogensen, C. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.406 · Cited by 90
Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study
Rossing, P. R., Hougaard, P., & Parving, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00556.x · Cited by 89
Sarafidis, P. A., Stafylas, P. C., Kanaki, A., & Lasaridis, A. N. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.206 · Cited by 88
Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study
Astrup, A. S., Tarnow, L., Rossing, P. R., Pietraszek, L., Hansen, P. R., & Parving, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00521.x · Cited by 86
Improved prognosis of diabetic nephropathy in type 1 diabetes
Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H., Hovind, P. H., Hansen, T. W., & Rossing, P. R. (2014) · Kidney International · doi:10.1038/ki.2014.206 · Cited by 72
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency
Shimizu, M., Furuichi, K., Yokoyama, H., Toyama, T., Iwata, Y., Sakai, N., Kaneko, S., & Wada, T. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0870-0 · Cited by 72
SKUPIEN, J. K., Smiles, A. M., Valo, E., Ahluwalia, T. S., Gyorgy, B., Sandholm, N., Croall, S., Lajer, M., McDonnell, K., Forsblom, C. M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1369 · Cited by 49
An Overview of Errors and Flaws of Estimated GFR versus True GFR in Patients with Diabetes Mellitus
Lima, S. L., & Porrini, E. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000453531 · Cited by 47
Longitudinal Changes in Estimated and Measured GFR in Type 1 Diabetes
de Boer, I. H., Sun, W., Cleary, P. A., Lachin, J. M., Molitch, M. E., Zinman, B., & Steffes, M. W. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050557 · Cited by 46
Tonolo, G., Velussi, M., Brocco, E., Abaterusso, C., Carraro, A., Morgia, G., Satta, A. E., Faedda, R., Abhyankar, A., Luthman, H., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001515 · Cited by 44
Ceriello, A., Rossi, M. C., Cosmo, S. D., Lucisano, G., Pontremoli, R., Fioretto, P., Giorda, C. B., Pacilli, A., Viazzi, F. C., Russo, G. T., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1471 · Cited by 37
Nonproteinuric Diabetic Nephropathy
Dwyer, J. P., & Lewis, J. B. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.006 · Cited by 35
Nonproteinuric progressive diabetic kidney disease
Zoccali, C., & Mallamaci, F. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000489 · Cited by 35
Jiang, S., Wang, Y., Zhang, Z., Dai, P., Yang, Y., & Li, W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.027 · Cited by 29
Long-term outcomes after AKI—a major unmet clinical need
Selby, N. M., & Taal, M. W. (2018) · Kidney International · doi:10.1016/j.kint.2018.09.005 · Cited by 27
Self-citationEffect of intensive treatment on diabetic nephropathy in patients with type I diabetes
Manto, A., Cotroneo, P., Marra, G., Magnani, P., Tilli, P., Greco, A. V., & Ghirlanda, G. (1995) · Kidney International · doi:10.1038/ki.1995.28 · Cited by 26
Zannad, F. M., Rossignol, P., Stough, W. G., Epstein, M., García, M. D. L. A. A., Bakris, G. L., Butler, J., Kosiborod, M., Berman, L., Mebazaa, A., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.127 · Cited by 25
Viazzi, F. C., Greco, E., Ceriello, A., Fioretto, P., Giorda, C. B., Guida, P., Russo, G. T., Cosmo, S. D., Pontremoli, R., & AMD-Annals Study Group (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488255 · Cited by 25
Leong, A. Y., Ekinci, E. I., Nguyen, C. D., Milne, M., Hachem, M., Dobson, M., MacIsaac, R. J., & Jerums, G. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0767-3 · Cited by 24
Budhiraja, P., Thajudeen, B., & Popovtzer, M. M. (2013) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2013.65a005 · Cited by 21
Albuminuria in type 2 diabetes mellitus: from remission to progression
Bentata, Y., Karimi, I., Benabdellah, N., Alaoui, F. E., Haddiya, I., & Abouqal, R. (2016) · Renal Failure · doi:10.3109/0886022x.2016.1138837 · Cited by 14
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Jin, Q., Liu, T., Qiao, Y., Liu, D., Yang, L., Mao, H., Ma, F., Wang, Y., Peng, L., & Zhan, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185317 · Cited by 431
Thipsawat, S. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211058856 · Cited by 307
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164
Albuminuria as a marker of systemic congestion in patients with heart failure
Boorsma, E. M., ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac528 · Cited by 70
Metadata
- Authors
- Selby, N. M., & Taal, M. W.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2020-04
- Volume
- 22
- Issue
- S1
- Pages
- 3-15
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W3014721260
- Cited by
- 764
- References
- 105
- FWCI
- 42.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.